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Abstract
Background: Ambient particulate matter (PM)-associated metals have been shown to play an
important role in cardiopulmonary health outcomes. To study the modulation of PM-induced
inflammation by leached off metals, we investigated intracellular solubility of radio-labeled iron
oxide (59Fe2O3) particles of 0.5 and 1.5 μm geometric mean diameter. Fe2O3 particles were
examined for the induction of the release of interleukin 6 (IL-6) as pro-inflammatory and
prostaglandin E2 (PGE2) as anti-inflammatory markers in cultured alveolar macrophages (AM) from
Wistar Kyoto (WKY) rats. In addition, we exposed male WKY rats to monodispersed Fe2O3
particles by intratracheal instillation (1.3 or 4.0 mg/kg body weight) to examine in vivo inflammation.
Results: Particles of both sizes are insoluble extracellularly in the media but moderately soluble in
AM with an intracellular dissolution rate of 0.0037 ± 0.0014 d-1 for 0.5 μm and 0.0016 ± 0.0012 d-
1 for 1.5 μm 59Fe2O3 particles. AM exposed in vitro to 1.5 μm particles (10 μg/mL) for 24 h increased
IL-6 release (1.8-fold; p < 0.05) and also PGE2 synthesis (1.9-fold; p < 0.01). By contrast, 0.5 μm
particles did not enhance IL-6 release but strongly increased PGE2 synthesis (2.5-fold, p < 0.005).
Inhibition of PGE2 synthesis by indomethacin caused a pro-inflammatory phenotype as noted by
increased IL-6 release from AM exposed to 0.5 μm particles (up to 3-fold; p < 0.005). In the rat
lungs, 1.5 but not 0.5 μm particles (4.0 mg/kg) induced neutrophil influx and increased vascular
permeability.
Conclusions:  Fe2O3  particle-induced neutrophilic inflammatory response in vivo and pro-
inflammatory cytokine release in vitro might be modulated by intracellular soluble iron via PGE2
synthesis. The suppressive effect of intracellular released soluble iron on particle-induced
inflammation has implications on how ambient PM-associated but soluble metals influence
pulmonary toxicity of ambient PM.
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Background
Ambient respirable particles vary in their size, chemical
composition, and surface characteristics. The toxicity of
PM differs based on the bioavailability of components
loosely adherent to particles and the surface chemistry [1].
Because ambient particles are heterogeneous due to their
diverse origin, the study of the contribution of each com-
ponent in causing lung cell response has been challeng-
ing. Particulate matter (PM) exposure causes pulmonary
inflammation and also cardiovascular health impact
[2,3]. Often a homogenous laboratory made respirable
particle preparation is used to delineate the role of each
component/characteristics in eliciting pulmonary and car-
diovascular effects. While it is postulated that the type of
initial pulmonary injury caused by PM influences cardio-
vascular effects, it is necessary to study pulmonary inflam-
matory potential of leached-off and adherent PM
components.
In this context, alveolar macrophages (AM) representing
the first line of pulmonary defense might play a central
role. As part of the innate immune system, they eliminate
invading pathogens and particles by phagocytosis, pro-
duce reactive oxygen species and thereby release cytokines
and lipid mediators to manage inflammatory processes
[4-6]. Among the lipid mediators, prostaglandin E2
(PGE2) predominantly exhibits immune-modulating
functions that limit inflammatory responses and control
tissue repair [7]. Ultrafine particles of different sizes are
able to activate the synthesis of lipid mediators such as
PGE2  [8,9]. Physicochemical properties are likely to
impact the mechanism by which pulmonary lipid media-
tors and pro-inflammatory cytokine-mediated inflamma-
tion occurs following exposure to PM.
Water-leachable particulate matter (PM)-associated tran-
sition metals have been shown to be one of the causative
components involved in acute pulmonary and cardiovas-
cular health effects [10-12]. Transition metals are frequent
contaminations of PM (such as residual oil fly ash) that
can mediate direct toxic effects on pulmonary epithelium
and macrophages [13,14]. However, the mechanism by
which each leached-off metal may modulate particle-core
effects on alveolar macrophages and ultimate inflamma-
tory responses are not clearly understood. In addition to
having direct cellular effects these loosely-bound or leach-
able metals may influence the macrophage phagocytosis
of insoluble particle core and the ultimate inflammatory
responses.
Iron is the ubiquitous transition metal found in greatest
abundance in ambient PM [15]. At high concentration in
different chemical forms and in the presence of reducing
equivalents in lung lining fluid, iron can initiate Fenton-
like reactions and generate highly reactive oxygen-derived
free radicals [16]. This oxidative stress resulting from the
interaction of the lung epithelium with catalytically-active
iron on the surface of ambient PM could promote adverse
health effects. However, such high concentrations of solu-
ble or surface reactive iron are less likely to be achieved by
inhalation of ambient particles. To prevent toxic effects by
catalytically-active cellular iron, lungs possess the ability
to transport and sequester free (as ferric [Fe3+] form) iron
in an inactive form using iron binding proteins [17].
However, it is not known how relatively small amounts of
leached-off iron within phagocytes may bind proteins and
initiate cell signaling which ultimately influences particle
core-induced inflammatory responses in the lung. To
study the mechanisms by which particle-associated solu-
ble iron modulate inflammatory responses induced by
solid particle core, we used physicochemical uniform iron
oxide (Fe2O3) particles of two different sizes.
Fe2O3 particles have low solubility in aqueous media but
can be more soluble in acidic milieu, such as within alve-
olar macrophages (AM) [18]. We have shown earlier that
intracellular solubility depends on the specific surface
area of the particles such that small particles with large
specific surface areas are more rapidly dissolved than
larger particles with smaller specific surface areas [18,19].
Thus, the use of such particle samples of different size pro-
vides the opportunity to investigate how core particle-
induced inflammatory response might be modulated by
the amount of metal that is leached. Recently nano-sized
iron oxide particles have been shown to induce lung
inflammation at high intratracheal instillation doses and
have been shown to translocate systemically, with a major
portion remaining in the lung several months post expo-
sure [20,21]. In the present study, we hypothesized that
soluble iron within AM plays a role in modulating Fe2O3
particle core-induced inflammatory responses in vitro and
in vivo. We further postulated that the level of prostaglan-
din E2 (PGE2) induction will modulate inflammation by
its anti-inflammatory action. Low cytotoxicity of carbonyl
iron particles has been speculated to be due to iron mod-
ulation of macrophage PGE2 production [22].
We selected physicochemical uniform Fe2O3 particles of
two different sizes (1.5 μm and 0.5 μm) and correspond-
ing surface areas (7.1 m2/g and 17 m2/g) for their extra-
and intracellular solubility and the ability to activate
inflammatory reactions in vitro and in vivo. We believed
that phagocytosed small Fe2O3 particles would yield more
soluble iron than large particles when incubated with AM
at an equivalent mass basis. Particles of these sizes (with
sufficient solubility differences) can be effectively phago-
cytosed by macrophages to allow the study of the role of
leached iron in modulating the iron core particle's inflam-
matory responses. Particle dissolution rates and produc-
tion of IL-6 (a pro-inflammatory cytokine) and PGE2 (anParticle and Fibre Toxicology 2009, 6:34 http://www.particleandfibretoxicology.com/content/6/1/34
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anti-inflammatory mediator) were examined using rat
AM. The inflammatory effect of the Fe2O3 particles was
also studied in vivo after intratracheal instillation into the
lungs of healthy Wistar Kyoto (WKY) rats. Our data dem-
onstrate that the amount of soluble iron released intracel-
lularly from phagocytosed Fe2O3  particles might
modulate PGE2  production and pro-inflammatory
cytokine release in vitro, and inflammation in the lung in
vivo.
Materials and methods
Materials
Phosphate buffered saline (PBS) with and without Ca2+/
Mg2+ was purchased from Biochrome (Berlin, Germany);
RPMI was from PAA Laboratories (Linz, Austria); fetal calf
serum, penicillin, streptomycin and amphotericin were
from Life Technologies (Eggenstein, Germany); all other
chemicals (analytical or HPLC grade were from Merck
(Darmstadt, Germany).
Animals
Twelve- to -14-wk-old, male Wistar Kyoto rats (WKY/
Kyo@Rj; Janvier, France) were used for bronchoalveolar
lavage to provide alveolar macrophages (AM) for the in-
vitro studies. These rats were housed in pairs in a humid-
ity- (55% relative humidity) and temperature- (22°C)
controlled room in individually ventilated cages (Venti-
rack™, cage type CU-31), maintained on a 12-h day/night
cycle prior to the study. Laboratory animal diet and water
was provided ad libitum. The studies were conducted
under Federal guidelines for the use and care of laboratory
animals and were approved by the Regierung von Ober-
bayern (District of Upper Bavaria, Approval No. 211-
2531-108/99 for rats) and by the GSF Institutional Ani-
mal Care and Use Committee. Twelve- to -14-wk-old,
male WKY rats were also used for in vivo intratracheal
instillation studies (Charles River, Raleigh, NC, USA).
These animals were housed in an isolated animal room in
the AAALAC-approved animal facility (21 ± 1°C, 50 ± 5%
relative humidity, 12 h light-dark cycle) and allowed free
access to standard 5001 Purina Rat Chow (Brentwood,
MO) and water. Institutional (EPA) Animal Care and Use
Committee approved the study protocol prior to the start
of the study.
Production of Fe2O3 particles
Two batches of monodisperse ferric oxide (Fe2O3) parti-
cles were produced from a solution of ferric nitrate
(Fe2(NO3)3) dispersed into droplets of the appropriate
concentration and uniform size by using a spinning top
aerosol generator. Droplets were dried at 140°C prior to
on-line thermal degradation at 800°C in a tube furnace.
Particles were prepared with and without labeling by 59Fe.
During generation, the aerodynamic characterization of
the particles was continuously monitored with an aerody-
namic particle sizer (Type APS33, TSI Inc.) and by low-
angle forward-scattering optical aerosol spectrometry
[23]. The physical size (count median diameter, CMD) of
the particles was determined by scanning electron micro-
scopy (SEM). The particles were spherical, with rough sur-
face area as also confirmed by transmission electron
microscopy (TEM). Density was calculated from the
median aerodynamic diameter and CMD. Specific surface
area was determined from TEM images and from BET
measurements of physicochemical uniform cobalt oxide
(Co3O4), terbium oxide (Tb4O7) and gadolinium oxide
(Gd2O3) particles of similar size and produced earlier
under same conditions [18,24-27].
Alveolar macrophages (AM) for in vitro study
AM from healthy WKY rats were isolated by bronchoalve-
olar lavages (repeated 5 times) using fresh aliquots of
Ca2+/Mg2+-free PBS kept at 37°C each time at a volume
equivalent to 28 mL/kg total lung capacity. After 20 min
centrifugation at 400 g cells were resuspended in RPMI
medium containing penicillin (100 U/mL), streptomycin
(100 U/mL), amphotericin (2.5 μg/mL) and 5% fetal calf
serum. Viability of cells was about 95% as estimated by
trypan blue exclusion. After May Grünwald Giemsa stain-
ing of cytospin preparations microscopic examination
identified about 95-99% of cells as AM. The RPMI
medium containing penicillin (100 U/mL), streptomycin
(100 U/mL), amphotericin (2.5 μg/mL) and 5% fetal calf
serum, referred as full medium below, was used for all the
in vitro incubations of cells with particles and control cells
without particles.
Determination of intracellular particle dissolution (IPD) by 
alveolar macrophages (AM)
Rat AM (1 × 105 cells/well) were incubated with 59Fe-
labeled 0.5 and 1.5 μm Fe2O3 particles in 96 well plates
for 12 days at 37°C, and the IPD of 59Fe2O3 particles in
AM was determined according to Kreyling et al [19].
Briefly, AM were incubated in full medium using a mon-
olayer technique in 96 well plates. AM were purified by
media exchange 2-4 hours later. With the new media
59Fe2O3 particles were added at a particle to AM ratio of
1:1. AM covered 5-10% (105 per well) of the well bottom.
These conditions allowed maintenance of fully functional
AM through the time of incubation without exchange of
media as had been optimized before. As described earlier
in detail [19] complete phagocytosis of the 59Fe2O3 parti-
cles (non-visible at the highest magnification ×600 of the
inverted microscope) within 24 hours was monitored by
quantifying phagocytosis of 2 μm fluorescent latex parti-
cles (FPSL) using an inverted microscope. For this test
FPSL were added to two separate wells at a FPSL to AM
ratio of 1:1. Complete phagocytosis was assumed after 24
hours when more than 90% of the FPSL were associated
with AM as oppose to only 10% after 30 min. The func-Particle and Fibre Toxicology 2009, 6:34 http://www.particleandfibretoxicology.com/content/6/1/34
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tional state of the AM was monitored during seven days of
incubation by determining the cell concentration and via-
bility in separate wells. IPD measurements were excluded
when any of the in vitro functions of AM were markedly
impaired.
During the next 7 days at 4 time points, intracellular dis-
solved 59Fe was determined by gamma spectroscopy in fil-
trates containing the dissolved 59Fe versus particulate
59Fe2O3 on filters of both the medium and the cell lysate.
First the cell culture medium was filtered (0.22 μm mem-
brane filter, Millipore, Schwalbach, Germany) providing
the dissolved 59Fe in the filtrate ADmed (t) and the particu-
late 59Fe2O3 APmed (t); then the cells were lysed in the wells
and subsequently the suspension of cell debris was fil-
tered, too. The filtrates of the cell lysates represented intra-
cellular dissolved iron ADlys  (t) which was retained
intracellularly while the filters contained the rest of partic-
ulate  59Fe2O3 (APlys (t). Dissolved and particulate iron
fractions DFj and PFj were obtained by normalizing activ-
ities ADj and APj by the sum of all four samples at a time t:
From the measured dissolution kinetics of time-depend-
ently increasing dissolved 59Fe fractions of the sum of AM
medium and lysate, a mean total IPD rate and standard
error were calculated, see Figure 1. For control, extracellu-
lar dissolved 59Fe concentrations DFext (t) were deter-
mined in parallel in full media without cells by filtrations
at the same time points t in order to determine the dis-
solved fractions DFext (t) of extracellular particulate frac-
tions PFext (t). From the measured dissolution kinetics of
time-dependently increasing dissolved fractions of the
sum of AM medium and lysate, a mean total IPD rate and
standard error were calculated, see Figure 1.
Note that dissolved factions DFmed (ti) + DFlys (ti) were
already corrected for externally dissolved DFext (ti). Data
and the fitted function of both particle sizes are shown in
Figure 1. The control data of extracellular 59Fe dissolution
in full media DFext (t) showed no time dependency but a
small immediate leaching effect at the beginning of incu-
bation.
In order to determine the uptake of free extracellular iron
by cultured AM, additional incubations were done and
the cellular uptake of Fe2+ from medium into AM was
measured. AM were incubated in 96 well-plates at 105 per
well (0.2 ml) and iron chloride (FeCl2) radio-labeled with
59Fe was added varying between 0.1 - 5.0 μg FeCl2/ml or
106 AM.
Analysis of IL-6 release and intracellular PGE2 synthesis
For the simultaneous determination of intracellular PGE2
synthesis and IL-6 release, AM of WKY rats (0.5 × 106 cells/
0.5 mL) were incubated with or without 10 μg/mL of
either 0.5 or 1.5 μm Fe2O3 particles in 48 well plates for
24 h at 37°C. Control cells were incubated under the
same conditions in parallel. After incubation of the cells,
the conditioned supernatants were isolated and stored at
-80°C for measurement of IL-6 release; the cells were then
deproteinized by addition of an eight-fold volume of 90%
methanol (containing 0.5 mM EDTA and 1 mM 4-
hydroxy-2,2,6,6-tetramethylpiperidine-1-oxide [pH 7.4])
to assess intracellular PGE2 content [9] and protein deter-
mination. The deproteinized cell suspensions were stored
at -40°C for 24 h followed by a two-time centrifugation at
10000 g for 20 min at 4°C with a 24 h interval to precip-
itate the protein. Aliquots of the deproteinized fractions
were dried in a vacuum centrifuge, and used for determi-
nation of PGE2. For protein determination, the precipi-
tated proteins were dried under nitrogen to remove any
methanolic solution, resuspended in half of the volume
in Hepes, pH 7.4, sonicated (3 times for 15 sec) and cen-
trifuged at 10000 g. The supernatants were taken for pro-
tein determination, measured with a 1:5 diluted Bio-Rad
solution (Bio-Rad, Munich, Germany) at 595 nm using
bovine serum albumin as standard. For inhibition experi-
ments with indomethacin, the cells were pretreated with
100 μM indomethacin for 15 min and subsequently incu-
bated with or without particles for 24 h.
The intracellular content of PGE2 was determined in the
deproteinized supernatants. Aliquots of the deproteinized
supernatants were dried in a vacuum centrifuge and used
for measuring PGE2 by a PGE2 specific enzyme immu-
noassay according to the instructions of the manufacturer
(Cayman, Ann Arbor, MI, USA).
The IL-6 release from particle-treated AM in the condi-
tioned supernatants was quantified by a rat specific IL-6
ELISA according to the instructions of the manufacturer
(Bender MedSystems, Vienna, Austria).
Intratracheal instillation of Fe2O3 particles into the lungs 
of WKY rats
In order to compare relative inflammatory potential of
each size particle, we selected two doses with three-fold
difference in the mass concentration. This allowed us to
compare similar surface area dose (1.3 mg of 0.5 μm par-
ticles and 4.0 mg of 1.5 μm particles) for at least one dose
level. Although these particles do not represent the com-
DF t AD t AD t AD t AP t  and AP t  j j j med lys med lys () ()/ [ () () () () ] ; =+ + = = med  lys ,
(1)
PF t AP t AD t AD t AP t  and AP t  j j j med lys med lys () ()/ [ () () () () ] ; =+ + = = med  lys ,
(2)
[ ( ) ( ) ( )] *[ exp( )]; DF t DF t DF t F  t  t med i lys i ext i tot tot i i +− = − − 1 l    all times t
(3)Particle and Fibre Toxicology 2009, 6:34 http://www.particleandfibretoxicology.com/content/6/1/34
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position of ambient PM in the surface characteristics, we
believe that these particles provide controlled experimen-
tal condition where the role of solubility of iron can be
determined. Although the concentrations we used are
orders of magnitude higher that one would encounter
environmentally at one time, these are the concentrations
that caused moderate degree of pulmonary injury and
inflammation without the overt toxicity. The dose levels
of 1.5 and 4.0 mg/kg body weights were also selected
based on the understanding that synthetic iron oxide par-
ticles will cause relatively mild inflammatory response in
the lungs [28]). Both 0.5 and 1.5 μm Fe2O3 particles were
suspended in sterile saline at two concentrations: 1.3 mg/
mL or 4.0 mg/mL, respectively. The WKY rats were then
intratracheally instilled at 1.0 mL/kg under halothane
anesthesia [29]. Control rats received 1 mL/kg sterile
saline only.
Analysis of bronchoalveolar lavage fluid (BALF)
Bronchoalveolar lavages of control and exposed rats were
done at 24 h after instillation according to Kodavanti et al.
[13]. Briefly, rats were anesthetized with sodium pento-
barbital (Nembutal, Abott Lab., Chicago, USA; 50-100
mg/kg body weight, intraperitoneal) and exsanguinated
via abdominal aorta. The tracheas were cannulated. The
lungs were lavaged using Ca2+ and Mg2+-free phosphate-
buffered saline (PBS; pH 7.4) at a volume of 28 mL/kg
body weight. Three in-and-out washes were performed
using the same fluid. One aliquot of lavage fluid was used
for determining total cells using a Coulter Counter (Coul-
ter, Inc., Miami, USA), and a second aliquot was centri-
fuged using a Shandon 3 Cytospin (Shandon Inc.,
Pittsburgh, PA, USA) for preparing cell differential slides.
After drying at room temperature the slides were stained
with LeukoStat (Fisher Scientific Co., Pittsburgh, PA,
USA). Macrophages, neutrophils, eosinophils and lym-
phocytes were quantified using light microscopy (200
cells/slide).
The remaining BALF was centrifuged at 1500 g to remove
cells, and the supernatant fluid was analyzed for protein,
albumin and lactate dehydrogenase (LDH) activity.
Assays for each endpoint were modified and adapted for
use on a Hoffmann-La Roche Cobas Fara II clinical ana-
lyzer (Roche Diagnostics, Indianapolis, IN, USA). Total
protein content was determined using a Coomassie Plus
Protein Assay Kit (Pierce, Rockford, IL, USA) with bovine
serum albumin as standard. The albumin content was
analyzed using a commercially available kit (ICN Star
Corporation (Stillwater, MN, USA). LDH activity was
determined using Kit 228 and standards from Sigma
Chemicals Co. (St. Louis, MO, USA).
Statistical analysis
Statistical significance was determined by analysis of vari-
ance and two-sample t-test. Changes with P < 0.05 were
considered significant.
Results
Characteristics of Fe2O3 particles
The physical characteristic of the two types of monodis-
perse Fe2O3 particles are listed in Table 1. The 1.5 μm par-
ticles have a surface area of 7 m2/g, whereas the smaller
0.5 μm particles have a larger surface area of 17 m2/g.
Density was calculated from the measured aerodynamic
median and the physical median diameter to be 3.8 g/cm3
for both particle sizes. In addition to Table 1, Figure 2
shows SEM images of both types of particles each at two
magnifications. The large 1.5 μm particles (Figure 2A)
with their magnification (Figure 2C) and the small 0.5 μm
particles (Figure 2B) with their magnification (Figure 2D)
show very well the spherical and porous structure of the
particles and their rough surface area.
Extra- and intracellular particle dissolution rate of 0.5 μm 
and 1.5 μm Fe2O3 particles
In a cellular in vitro system with rat AM both types of
59Fe2O3 particles were evaluated for their extra- and intra-
Intracellular and extracellular dissolution of 1.5 and 0.5 μm  59Fe2O3 particles in alveolar macrophages (in vitro study) Figure 1
Intracellular and extracellular dissolution of 1.5 and 
0.5 μm 59Fe2O3 particles in alveolar macrophages (in 
vitro study). Rat alveolar macrophages (AM) or incubation 
media without AM were incubated in vitro with 59Fe-labeled 
0.5 μm Fe2O3 particles and 1.5 μm Fe2O3 particles, respec-
tively. The intracellular particle dissolution (IPD) rate for 
cells of 4 different animals (n = 4) and the extracellular disso-
lution for 4 different incubations without cells (n = 4) were 
determined over a period of 7 days. The small 0.5 μm parti-
cles exhibited a higher IPD rate (0.0037 ± 0.0014 d-1; n = 4) 
than the large 1.5 μm particles (0.0016 ± 0.0012 d-1; n = 4); 
both rates were corrected for extracellular particle dissolu-
tion see equation 3. The extracellular dissolution rate for 
both types of particles was negligible small.Particle and Fibre Toxicology 2009, 6:34 http://www.particleandfibretoxicology.com/content/6/1/34
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cellular dissolution rates over 10 days (Figure 1). In the
medium without AM, a small dissolved iron fraction
occurred initially, but particles did not dissolve any more
thereafter suggesting that the extracellular dissolved frac-
tion remains constant during the incubation time. The
extracellular dissolved fraction of the incubated 0.5 μm
particles was 0.00055 ± 0.00022 and for 1.5 μm particles
was 0.00034 ± 0.00016. In contrast, the intracellular dis-
solved fractions increased with time. The intracellular par-
ticle dissolution (IPD) rates from 0.5 and 1.5 μm 59Fe2O3
particles were 0.0037 ± 0.0014 d-1 and 0.0016 ± 0.0012 d-
1, respectively. From the least square fitted data these rates
differed significantly (p < 0.01) between both particle
sizes; in addition, when applying least square fits to the
extracellular dissolved fractions of both particle sizes,
those rates were very close to zero and differed signifi-
cantly (p < 0.001) to the IPD rates of the two particle sizes.
From the particle dissolution kinetics data determined
from measures of iron in the culture medium and cell
lysate (corrected for external dissolved Fe), we found that
more than 70% of the dissolved iron remained within AM
(likely iron binding protein-associated), whereas only
30% was released out of the cell into the extracellular
medium. In fact, we cannot exclude trafficking of dis-
solved Fe back and forth across AM membranes according
to the complex iron metabolism since we only measure
the net effect. In comparison, our recent studies on mod-
erately soluble cobalt oxide particles [19] showed that the
intracellular dissolved and retained cobalt was only 5-
10% since most dissolved cobalt was released rapidly out
of the AM. This is in contrast to the fate of the dissolved
iron in this study since it was predominantly retained -
most likely associated with iron binding proteins - in AM.
Furthermore, extracellular iron Fe2+ at doses between 0.1-
5 μg/mL medium (or per 106 AM) was taken up relatively
weakly by AM (24 ± 2.5% of any of the doses provided).
Hence, these data show that the dissolved iron from
phagocytosed particles was primarily retained intracellu-
larly while relatively small fractions of external dissolved
iron were sequestered by AM. After one week the intracel-
lular dissolved and retained iron progressively increased
to about 3% with small and 1% with large 59Fe2O3 parti-
cles (Figure 1). This amount of intracellular available sol-
uble iron is important for the cellular responses as shown
below.
Cellular effects of 1.5 μm and 0.5 μm Fe2O3 particles: 
release of IL-6 and synthesis of PGE2
Both types of Fe2O3 particles were evaluated for their
capacity to produce and release inflammatory and anti-
inflammatory mediators such as IL-6 and PGE2 from rat
AM. To elucidate whether one of these parameters affect
the other, the AM incubations with particles were per-
formed in the absence and presence of indomethacin, an
inhibitor of PGE2 synthesis. IL-6 release in the media and
PGE2 in cells were analyzed with or without one of the two
sized iron oxide particles. As shown in Figure 3A, in the
absence of indomethacin the release of IL-6 was signifi-
cantly induced by AM exposed to the large 1.5 μm parti-
cles (1.8-fold; *P < 0.05) but not by those treated with the
small 0.5 μm particles. In the presence of indomethacin
the IL-6 release increased strongly by both types of parti-
cles (**P < 0.005) compared to non-particle baseline. The
significant difference in IL-6 release between the large and
the small particles in the absence of indomethacin (#P <
0.01) was not observed in the presence of indomethacin.
Figure 3B shows that in the absence of indomethacin the
intracellular PGE2 synthesis is enhanced by the large (1.9-
fold; *P < 0.05) and even more by the small particles (2.5-
fold; **P < 0.005) compared to non-particle baseline.
Moreover there was a significant difference for PGE2 syn-
thesis between the large and the small particles (#P <
0.01). However, inhibition by indomethacin abolished
these significant differences of PGE2 production for both
types of particles due to the inhibition of PGE2 synthesis.
These data reveal that the suppressive effect of the small
particles on IL-6 release (Figure 3A) was caused by an
Table 1: Physical characteristics of Fe2O3 particles
Physical Characteristics Large Particles Small Particles
Geometric median diameter (μm) 1.5 0.5
Aerodynamic median diameter (μm) 2.8 1.3
Geometric Standard Deviation 1.2 1.2
Density (g/cm3) 3.8 4.1
Estimated surface area (m2/g) 7.1 17
The monodisperse Fe2O3 particles were produced using a spinning top aerosol generator with subsequent online heat degradation of the particles 
in a tube furnace at 800°C. The aerodynamic characterization of the particles was continuously monitored with an aerodynamic particle sizer (Type 
APS33, TSI Inc.) and by low-angle forward-scattering optical aerosol spectrometry.Particle and Fibre Toxicology 2009, 6:34 http://www.particleandfibretoxicology.com/content/6/1/34
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enhanced PGE2 synthesis (Figure 3B) compared to the
large particles.
Bronchoalveolar lavage fluid (BALF) analysis of lung 
inflammation and injury
Because particle number concentration and relative sur-
face area for 0.5 μm Fe2O3 particles are greater than for the
1.5 μm particles per given treatment concentration, one
would expect greater phagocytosis of the smaller particles,
and thus, greater injury and inflammation in vivo. In order
to evaluate relative in vivo toxicity and inflammatory
potential of 0.5 μm versus 1.5 μm particles, healthy WKY
rats were intratracheally instilled with these Fe2O3 parti-
cles, respectively, at a dose of 1.3 mg/kg body weight and
4.0 mg/kg body weight. At 24 h after instillation pulmo-
nary injury was assessed by analysis of injury markers in
the BALF of control and exposed rats. As shown in Figure
4A and contrary to what was expected, the content of pro-
tein in the BALF increased significantly in the rats exposed
to 1.5 μm particles at both dose-levels, whereas that in
BALF of rats exposed to 0.5 μm did not change. Similarly,
the content of albumin in the BALF was also elevated fol-
lowing exposure to the 1.5 μm particles at both dose-lev-
els, but not after exposure to the 0.5 μm particles (Figure
4B), confirming the larger particles' effect on the protein
content of BALF. Moreover, the LDH activity as a marker
for cell integrity slightly increased only in rats exposed to
1.5 μm Fe2O3 particles at 4.0 mg dose-level (Figure 4C).
No change in lavageable AM was noted with either parti-
cle (Figure 5A). The number of neutrophils in BALF
increased significantly after exposure of the rats to the 1.5
Scanning electron microscope (SEM) pictures of the 1.5 μm and 0.5 μm Fe2O3 particles Figure 2
Scanning electron microscope (SEM) pictures of the 1.5 μm and 0.5 μm Fe2O3 particles. SEM of 1.5 μm Fe2O3 par-
ticles (panels A + C) and of 0.5 μm Fe2O3 particles (panels B + D); magnifications of original SEM pictures in panels A + B are 
5K; magnification of close-ups of SEM pictures in panel C is 13K and in panel D is 17K. The larger magnifications show the 
rough surface area of the spherical Fe2O3 particles of both sizes as an indicator for their moderate porosity.Particle and Fibre Toxicology 2009, 6:34 http://www.particleandfibretoxicology.com/content/6/1/34
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μm particles at a dose of 4 mg/kg body weight, whereas
the 0.5 μm particles did not induce an influx of neu-
trophils (Figure 5B). The instilled particles were readily
taken up by AM during the exposure regardless of the size
difference. This was apparent when examining BALF cell
differential slides under light microscopy (not shown).
These data indicate that the large 1.5 μm but not small
particles induced an inflammatory response and
increased vascular permeability in the rat lungs at the
highest dose tested.
Discussion
There is some evidence to believe that soluble PM-associ-
ated iron at low concentrations may have inhibitory effect
on PM-induced inflammation [13], however, the mecha-
nism and role of soluble iron or other metals in modulat-
ing solid particulate core-induced inflammation are
unknown. Because iron is ubiquitously present in ambi-
ent PM with differing water solubility [13,14] its role in
modulating PM-induced inflammatory responses
becomes critical in the toxicity of ambient PM. The
present study was designed to determine the role of leach-
able iron in particle core-induced inflammatory responses
in vitro within AM and in vivo in rats using Fe2O3 particles
of two different sizes and dissolution kinetics. The parti-
cles we used were spherical with a porous structure and a
rough surface area as outlined in Figure 2. We report here
that while Fe2O3 particles are insoluble extracellularly,
intracellular dissolution do occur with the IPD being
greater for 0.5 than 1.5 μm Fe2O3 particles, as expected
based on the difference in the specific surface area (Table
1 and Figure 1). For the biologic response of the cells we
have studied the effect of the particles on the release of IL-
6 as inflammatory marker and on the intracellular synthe-
sis of PGE2 as immune-modulating and anti-inflamma-
tory mediator also involved in resolution of
inflammation. We have focused specifically on responses
of IL-6 because of its importance as acute phase protein as
well as pro- and anti-inflammatory cytokine. With regard
to these properties, a close relationship between IL-6 and
PGE2  via an IL-10 dependent mechanism has been
recently reported [30]. While only the large 1.5 μm but
not the small 0.5 μm Fe2O3 particles caused a substantial
IL-6 release from AM (Figure 3A), cellular PGE2 produc-
tion was much greater with the small 0.5 μm Fe2O3 parti-
cles compared to the large ones (Figure 3B). This
difference is emphasized when the relative effects of large
and small particles for IL-6 release and PGE2 synthesis are
opposed (Figure 3). Inhibition of particle-induced PGE2
by COX inhibitor indomethacin further enhanced the
production of the pro-inflammatory cytokine IL-6 by both
sizes to similar levels, so that the significant difference
between both particles types was not anymore observed
(Figure 3A). Due to this observation we suggest that solu-
ble iron arising from dissolved iron particles within AM
modulates particle-induced IL-6 production via PGE2.
Further, in vivo intratracheal instillation of 1.5 μm parti-
cles with a lower IPD rate induced lung inflammation and
injury in rats while 0.5 μm particles were less effective,
consistent with production of IL-6 in vitro. These in vitro
and in vivo data together demonstrate that dissolved intra-
IL-6 release and PGE2 synthesis in alveolar macrophages by  1.5 and 0.5 μm Fe2O3 particles (in vitro study) Figure 3
IL-6 release and PGE2 synthesis in alveolar macro-
phages by 1.5 and 0.5 μm Fe2O3 particles (in vitro 
study). Rat alveolar macrophages were incubated with large 
1.5 μm or small 0.5 μm Fe2O3 particles for 24 h in RPMI, 
respectively, and studied in absence and presence of PGE2 
synthesis inhibitor indomethacin: (A) release of IL-6 as pro-
inflammatory mediator, and (B) synthesis of PGE2 as anti-
inflammatory and immune-modulating mediator. Data are 
given as mean ± SD of the percentages for IL-6 release and 
PGE2 synthesis obtained from cells of 4 different animals (n = 
4). Baseline value represents 100% of IL-6 release with 304 ± 
105 pg/mL (n = 4), and 100% for PGE2 synthesis with 408 ± 
140 pg/mL (n = 4). P-values (* P < 0.05; ** P < 0.005) for sig-
nificant difference between baseline and particle-treated cells 
in the absence and presence of indomethacin and (# P < 
0.01) for significant difference between large 1.5 μm and 
small 0.5 μm Fe2O3 particles in absence of indomethacin for 
IL-6 release (A) and PGE2 synthesis (B).Particle and Fibre Toxicology 2009, 6:34 http://www.particleandfibretoxicology.com/content/6/1/34
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cellular iron modulates pulmonary inflammatory
responses induced by insoluble Fe2O3 particle core in rats.
To examine the role of dissolved iron, we chose physico-
chemical uniform Fe2O3 particles with two different sizes
and, hence, two different specific surface areas such that
when incubated at equal mass concentration with AM,
smaller 0.5 μm particles will cause greater release of solu-
ble iron than 1.5 μm particles. Our AM culture data con-
firm that smaller Fe2O3  particles dissolve more iron
intracellularly than particles of 1.5 μm size owing to the
differences in the specific surface area. Because both sizes
of particles are likely to be readily taken up by AM, we
could determine the role of intracellular iron-solubility in
eliciting particle-induced inflammatory responses in vitro
and in vivo. Since Fe2O3 particles were minimally soluble
extracellularly, the greater dissolution of Fe2O3 particles
within phagolysosomes supports the greater solubility of
PM-associated metals in acidic milieu.
PM-associated metals can be released within the alveolar
lining fluid or in cells depending upon their level of solu-
bility and thus, within each compartment they can affect
unique cell processes. Extracellular metal can also be
internalized by cells, or metal can be released from parti-
cles within cells after particles have been phagocytosed. In
the present study, there was no dissolved iron extracellu-
larly since the particles leached minimally in the medium
without cells. However, particles dissolved in a time-
dependent fashion only in the acidic milieu of the
phagolysosomes of AM. Furthermore, the intracellular
dissolved iron was primarily retained in the cells as
observed with AM culture data. Since extracellular iron
was minimal, it is unlikely that this iron pool modulated
AM responses. Iron being ubiquitously and most abun-
dantly present metal in ambient PM with varying solubil-
ity, and as being an essential metal that is tightly regulated
physiologically by endogenous cellular processes, the
modulation of solid particle-induced inflammation by
soluble iron becomes critical in understanding ambient
PM-induced pulmonary damage. Antagonistic effect of
soluble iron in combustion particles induced inflamma-
tion has been suggested [13,31]. Intracellular iron can
bind to a variety of iron binding proteins, cell membrane
transporters and iron sequestering proteins such as trans-
ferrin and ferritin [32]. Depending upon the binding
affinity of each of these proteins or specific protein bind-
ing sites within the same protein, iron may modulate cell
signaling processes induced by phagocytosed particles.
The fact that dissolved iron released from particles within
phagolysosome remained intracellularly without produc-
ing marked cellular injury supports the idea that proteins
within cells were able to bind released iron.
Externally added vanadium and zinc have been shown to
inhibit phosphatases and induce kinase-specific signaling
in cells and subsequent inflammation [33]. Hisakawa et
al. [34] observed a depletion of PGE2 in human synovial
fibroblasts by soluble ferric citrate, which could be
reversed by the presence of desferrioxamine. Interestingly,
these authors found a comparable increase of PGE2 by
desferrioxamine in absence of ferric citrate. This suppres-
sive effect of soluble ferric citrate on PGE2 in fibroblasts
[34] contrasts our findings that more soluble iron
Injury markers in BALF of rat lungs after instillation of 1.5  and 0.5 μm Fe2O3 particles (in vivo study) Figure 4
Injury markers in BALF of rat lungs after instillation 
of 1.5 and 0.5 μm Fe2O3 particles (in vivo study). 
Healthy WKY rats were intratracheally instilled with 1.5 μm 
or 0.5 μm Fe2O3 particles, respectively, at a dose of 1.3 mg/
kg body weight and 4.0 mg/kg body weight. At 24 h after 
instillation pulmonary injury was assessed in the BALF of 
control and exposed rats. Protein (A) and albumin levels (B) 
in BALF were determined as markers for vascular permeabil-
ity, and LDH activity (C) as marker for cytotoxicity. The data 
are given as mean ± SD with (n = 6) representing 6 animals 
for each dose and type of particles. * P-value (> 0.05) for sig-
nificant difference between saline control and Fe2O3 particle 
exposed rats.
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enhances PGE2 synthesis in AM. Reasons for this discrep-
ancy between the two studies may be due to the amount
of soluble iron that existed in extracellular milieu in the
Hisakawa study. Existence of large amounts of iron in
extracellular fluid may overwhelm protein binding capac-
ity and promote Fenton-like reaction. In case of AM
treated with carbonyl iron particles, PGE2 production was
increased [22] as observed in the present study. This
increase in PGE2 was correlated with low cytotoxicity of
iron particles. In addition, iron oxide particles, larger (2.6
μm) than what was used in our study, induced an acute
transient inflammation after instillation in human and rat
lungs [28]. These authors found an influx of PMN in the
lungs and increased levels of protein, LDH, IL-6 and IL-8
in BAL fluid, whereas PGE2 was only marginally elevated.
Furthermore, there is evidence for a relationship between
IL-6 and PGE2 production, since exposure of NO2 to rats
decreased the levels of TNF- and IL-6 in BAL fluids,
whereas PGE2 production was increased [35]. PGE2 may
exert anti-inflammatory effect via its influence on IL-10
production [36]. Since both, IL-6 and PGE2 have been
shown to be associated with inflammatory responses and
anti-inflammatory repair mechanisms, the temporality of
induction of each mediator, likely play a crucial role in
their functionality.
Our data supports the hypothesis that soluble iron within
AM modulates particle-core induced inflammatory
responses via increased PGE2 synthesis and inhibiting IL-
6 release. We have recently shown in in vitro studies that
ultrafine particles induce PGE2 production and this effect
is modulated by particle size, specific surface area and
composition [8,9]. The particle-induced release of PGE2
by AM affects neutrophil respiratory burst activity. The
supernatants of particle-treated AM, containing PGE2,
reduced the respiratory burst activity of stimulated neu-
trophils, which was restored to control level when PGE2
production was prevented in AM by COX inhibitors [8].
Likewise, in the present study, the lack of IL-6 release was
associated with higher PGE2 production by AM incubated
with smaller 0.5 μm particles, while larger 1.5 μm parti-
cles produced significantly more IL-6 with less remarkable
PGE2. Since the intracellular dissolution rate of 0.5 μm
particles was greater than that of 1.5 μm particles, it can be
concluded that the inflammatory response of small Fe2O3
particles was inhibited due to higher PGE2 production
caused by higher levels of soluble iron within AM. The
role of PGE2 in production of IL-6 by AM is further con-
firmed by restoration of IL-6 release in AM with 0.5 μm
Fe2O3 particles in the presence of PGE2 synthesis inhibi-
tor, indomethacin. PGE2  has been recently shown to
enhance the production of endogenous IL-10 [30] which
plays a central role in the down-regulation of pro-inflam-
matory cytokines such as IL-6 and TNF in dendritic cells
[36,37]. We therefore propose that small sized iron oxide
particles activate a mechanism which attenuates inflam-
matory responses to these particles based on an IL-10
dependent cross-regulation between PGE2 and IL-6 acting
as a protective pathway in phagocytes, which should be
analyzed in further studies.
The conclusion that the presence of intracellular soluble
iron suppresses PM-induced inflammation is further sup-
ported by the in vivo assessment of pulmonary inflamma-
tory response in rats following intratracheal instillations
of large 1.5 and small 0.5 μm Fe2O3 particles. One would
expect that greater specific surface area and number con-
centration at a given mass of 0.5 μm Fe2O3 particles than
that of 1.5 μm particles would lead to higher phagocytosis
by AM resulting in greater particle-core induced injury and
inflammation. However, we observed that neutrophilic
inflammation and lung injury were more pronounced in
rats instilled with the large Fe2O3 particles than the small
particles with the latter resulting in higher release of solu-
ble iron within cells. In vivo, human exposure to Fe2O3
particles of >2.5 μm has been shown to cause inflamma-
Inflammatory cells in BALF of rat lungs after instillation of 1.5  and 0.5 μm Fe2O3 particles (in vivo study) Figure 5
Inflammatory cells in BALF of rat lungs after instilla-
tion of 1.5 and 0.5 μm Fe2O3 particles (in vivo study). 
Healthy WKY rats were intratracheally instilled with 1.5 μm 
or 0.5 μm Fe2O3 particles, respectively, at a dose of 1.3 mg/
kg body weight and 4.0 mg/kg body weight. At 24 h after 
instillation pulmonary immune cells such as alveolar macro-
phages (A) and neutrophils (B) were assessed in the BALF of 
control and exposed rats. The data are given as mean ± SD 
with (n = 6) representing 6 animals for each dose and type of 
particles. * P-value (< 0.05) for significant difference between 
saline control and Fe2O3 particle exposed rats.
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tion following intrabronchial instillation [28]. Although
our particles likely not mimic the characteristics of ambi-
ent particles, the present study supports the hypothesis
that the amount of soluble iron from particulate matter
can modulate particle core-induced inflammatory
responses.
Conclusions
In conclusion, increased intracellular soluble iron may
modulate Fe2O3 particle-induced IL-6 release and inflam-
matory response via PGE2  production by AM. This is
based on the evidence that greater solubility of 0.5 μm
particles resulting in higher intracellular soluble iron was
associated with higher PGE2 production and suppressed
IL-6 release when compared to 1.5 μm particles. The sup-
pressive effect of intracellular released soluble iron on par-
ticle-induced inflammation has implication on how
ambient PM-associated but soluble metals influence pul-
monary toxicity of ambient PM.
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